Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ekso Bionics Holdings (EKSO) Asset Writedowns and Impairment (2016 - 2025)

Ekso Bionics Holdings has reported Asset Writedowns and Impairment over the past 11 years, most recently at $758000.0 for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 1138.36% to $758000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $778000.0, a 1015.29% increase, with the full-year FY2025 number at $750000.0, changed N/A from a year prior.
  • Asset Writedowns and Impairment reached $758000.0 in Q4 2025 per EKSO's latest filing, up from $20000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $758000.0 in Q4 2025, with the low at -$73000.0 in Q4 2024.
  • The 5-year median for Asset Writedowns and Impairment is $15000.0 (2023), against an average of $58200.0.
  • Peak YoY movement for Asset Writedowns and Impairment: crashed 1300.0% in 2024, then skyrocketed 1138.36% in 2025.
  • Tracing EKSO's Asset Writedowns and Impairment over 5 years: stood at $27000.0 in 2021, then surged by 62.96% to $44000.0 in 2022, then increased by 6.82% to $47000.0 in 2023, then plummeted by 255.32% to -$73000.0 in 2024, then skyrocketed by 1138.36% to $758000.0 in 2025.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $758000.0, $20000.0, and -$73000.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.